JPY 4,974.00
−1.87%Research · Aug 27, 2026
Drug Royalty Holders Turn Royalties Into Dividends
Neuren pays out 70-100% of its DAYBUE royalty after just USD3m of half-year admin cost; BioArctic paid a SEK177m dividend in June and still held about SEK2bn of cash.